Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Jiangsu vcare pharmaceutical technology co., LTD clinical trials
The registry lists 35 studies whose lead sponsor is Jiangsu vcare pharmaceutical technology co., LTD. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Keep track of what changes. Save the Jiangsu vcare pharmaceutical technology co., LTD studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jiangsu vcare pharmaceutical technology co., LTD.
- Jiangsu vcare pharmaceutical technology co., LTD35 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 35 of 35.
- A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataRecruitingNCT07762443Phase 1
- A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental VitiligoNot yet recruitingNCT07828639Phase 1/2
- Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult SubjectsNot yet recruitingNCT07796191Phase 1
- Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia AreataRecruitingNCT07749716Phase 2
- A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone MetastasesNot yet recruitingNCT07731685Phase 1
- Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisRecruitingNCT06723080Phase 3
- Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)RecruitingNCT06577519Phase 3
- Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid TumorsRecruitingNCT06658353Phase 3
- Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic DermatitisRecruitingNCT07592585Phase 3
- A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT07598383Phase 2
- Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.RecruitingNCT07172360Phase 3
- Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental VitiligoRecruitingNCT07172347Phase 2
- Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT07551557Phase 1
- Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal FunctionCompletedNCT07551570Phase 1
- A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.CompletedNCT07533851Phase 1
- Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic DermatitisCompletedNCT06891040Phase 2
- Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic DermatitisCompletedNCT07329101Phase 1
- Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal MetabolizersCompletedNCT07067775Phase 1
- The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male VolunteersCompletedNCT06974292Phase 1
- Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic DermatitisCompletedNCT06009094Phase 1
- A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsCompletedNCT06619951Phase 1
- Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult SubjectsCompletedNCT06529445Phase 1
- Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT05997927Phase 2
- Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.CompletedNCT05814939Phase 2
- A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.CompletedNCT05874622Phase 1
- PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 MetabolizersCompletedNCT05162053Phase 1
- Assessment of the Effect of Omeprazole on Vicagrel in Healthy SubjectsStatus unknownNCT05651074Phase 1
- The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid TumorsStatus unknownNCT04614740Phase 1/2
- Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsCompletedNCT05528120Phase 1
- Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy SubjectsCompletedNCT05354752Phase 1
- Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy SubjectsCompletedNCT05138770Phase 1
- A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult SubjectsCompletedNCT04919551Phase 1
- The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy ManCompletedNCT04143750Phase 1
- The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for VicagrelCompletedNCT03599284Phase 2
- Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19CompletedNCT03942458Phase 1